Overview of Alce

Property	Description
Active Ingredient	Cetirizine Hydrochloride
Forms	Tablet, Oral Solution, Syrup
Pharmacological Class	Second-Generation Antihistamine
Common Use	Relief from Allergic Conditions
Origin	Synthetic (Metabolite of Hydroxyzine)

What Type of Medicine is Alce?

Alce is a common trade name for a medication whose active ingredient is Cetirizine Hydrochloride, which is classified pharmacologically as a second-generation antihistamine. This class of medicine is primarily utilized to counteract reactions triggered by the body’s natural immune response to allergens. Cetirizine Hydrochloride is a synthetic, orally active drug that is a highly selective H1-receptor antagonist. It represents an advancement over older agents because it is the active racemic compound and metabolite of hydroxyzine, designed to minimize the sedation effects often associated with the first-generation antihistamines. The classification as a second-generation agent indicates a highly targeted action on peripheral H1 receptors, which has been clinically recognized for effective relief across different age groups.

Composition, Forms, and General Purpose

The medication is manufactured as a single-ingredient product, centering exclusively on the action of Cetirizine Hydrochloride. It is typically administered via the oral route and is widely available in several high-level dosage forms, including the familiar tablet, as well as liquid preparations such as an Oral Solution or Syrup. The Oral Solution is often preferred for pediatric patient groups due to ease of ingestion. The general purpose of the medication is rooted in its ability to block the effects of the key chemical messenger histamine, which the body releases during an allergic episode. By acting as a selective antagonist against histamine, the drug provides foundational relief from the general discomfort and physical manifestations of various common allergic conditions, offering typical relief from symptoms like sudden onset of sneezing or persistent itching.

What side effects are possible with Alce?

Official Safety Profile of Cetirizine Hydrochloride

Adverse reactions associated with Cetirizine Hydrochloride are formally classified by frequency and organized by the affected System-Organ Class (SOC) in official regulatory documents. This structure defines the expected risk profile of the medication, moving from highly common, expected effects to rare, clinically significant events.

Common adverse reactions, defined as occurring in 1 to 10 users per 100, frequently involve the Nervous System and General Disorders. These include somnolence (drowsiness), fatigue, headache, and dizziness. Gastrointestinal effects such as dry mouth are also classified as common. The frequency of certain effects, like somnolence and fatigue, is noted in regulatory documents to be more prominent at the initiation of treatment.

Less frequent adverse reactions, classified as Uncommon or Rare, affect various physiological systems. Uncommon reactions may include nausea, diarrhea, abdominal pain, or localized issues like pruritus (itching) and rash.

Serious Adverse Reactions are classified as Rare or Very Rare events. These include systemic responses such as hypersensitivity reactions (including very rarely anaphylactic shock) and rare instances of hepatitis or tachycardia (increased heart rate).

Population-Specific Safety Constraints

Official labels detail safety considerations based on patient physiology, primarily tied to the drug’s excretion. Due to its reliance on the kidneys for clearance, the medicine is contraindicated in individuals with severe renal impairment. Caution is also advised for older adults due to the higher likelihood of reduced renal function in this population, which may increase the risk of adverse reactions. Furthermore, rare cases of severe itching and/or hives have been reported upon discontinuation after long-term administration.

Overdose and Emergency Response

Alce Overdose and When to Seek Help

Official regulatory documents define the overdose profile of this substance by detailing expected symptoms and the necessary emergency responses.

Documented Overdose Symptoms

Symptoms associated with an acute overdose exposure may include common systemic and gastrointestinal disturbances. Regulatory information specifies that symptoms can involve:

Central Nervous System Effects: Drowsiness and a general lack of energy.
Gastrointestinal Effects: Nausea, vomiting, and stomach pain.

When to Seek Emergency Medical Attention

Immediate professional help should be sought for any suspected overdose. Certain signs indicate a severe systemic risk and necessitate an immediate call to emergency medical services:

Collapse
Seizures
Trouble breathing

Overdose Management Principles

Management of an overdose is primarily supportive, as there is no specific antidote for this substance listed in regulatory guidance. Treatment typically involves supportive care and measures aimed at gastrointestinal decontamination, such as the removal of any unabsorbed material. Immediate clinical monitoring and professional attention are required to manage symptoms and stabilize the patient.

Therapeutic Uses of Alce

What Alce treats: main uses and benefits

Alce (donepezil hydrochloride) belongs to a class of medications known as acetylcholinesterase inhibitors. It is primarily used to manage symptoms associated with various stages of dementia in individuals diagnosed with Alzheimer’s disease.

Main Uses

The medication is indicated for the symptomatic treatment of Alzheimer's disease. While it is not a cure for the underlying condition, it is used to manage cognitive and functional symptoms in patients with:

Mild Alzheimer's disease: Addressing early-stage symptoms where individuals may experience minor memory loss or confusion.
Moderate Alzheimer's disease: Assisting as symptoms progress and begin to interfere more significantly with daily activities.
Severe Alzheimer's disease: Managing advanced symptoms to help maintain basic functional abilities for as long as possible.

How it Works

In individuals with Alzheimer’s disease, levels of acetylcholine—a naturally occurring chemical in the brain involved in memory, learning, and communication between nerve cells—tend to be lower than normal. Alce works by inhibiting the enzyme responsible for breaking down acetylcholine. By increasing the availability of this chemical in the brain, the medication helps facilitate better communication between nerve cells.

Potential Benefits

The primary goal of treatment with Alce is to support cognitive function and improve the quality of daily life. The benefits observed during treatment may include:

Cognitive Support: Improvements or stabilization in memory, orientation, and language skills.
Functional Maintenance: Aiding the patient’s ability to perform routine daily tasks, such as dressing or eating.
Behavioral Stabilization: Helping to manage some of the behavioral and psychological symptoms associated with dementia, such as agitation or apathy.

It is important to note that the effectiveness of the treatment varies between individuals. Some patients may experience noticeable improvements, while in others, the medication may slow the rate of cognitive decline without reversing existing symptoms.

Regulatory References

NIH StatPearls overview on Cetirizine

Eligibility and Restrictions for Use

The population eligibility for Alce (Cetirizine Hydrochloride) is strictly defined by regulatory authorities based on age, organ function, and pre-existing conditions.

Populations Officially Restricted or Excluded

The medicine is formally contraindicated and must not be used by individuals with a known hypersensitivity to the active substance, its metabolite levocetirizine, or its parent compound, hydroxyzine. Absolute exclusion is also mandated for patients with severe renal impairment or End-Stage Renal Disease (ESRD), particularly those requiring dialysis.

Age- and Organ-Specific Eligibility

Use is generally permitted for adults, adolescents, and children starting from six months of age for certain formulations, though the oral tablet form is not recommended for children under six years. Safety and effectiveness are not established in infants younger than six months.

For patients with moderate renal impairment, use is conditional, and careful assessment of kidney function is required. In contrast, patients with solely hepatic impairment typically do not require specific eligibility restrictions.

Conditional Physiological States

Use during pregnancy requires caution and should only occur if the therapeutic benefit is deemed necessary. Use is generally not recommended during lactation as the substance is excreted into human milk. Caution is also advised for patients with a risk of convulsions or those with predisposing factors for urinary retention.

What should I know about interactions with other medicines?

Alce Interactions with other medicines and products

The regulatory interaction profile for Alce is defined by specific pharmacodynamic cautions and documented pharmacokinetic alterations, strictly based on official government labeling.

Pharmacodynamic Interactions

The most critical interaction pattern involves the Central Nervous System (CNS). Co-administration with Alcohol or other CNS Depressants, such as sedatives and tranquilizers, may lead to an additional reduction in alertness and further impairment of performance due to additive effects. Official regulatory documents advise caution with these combinations.

Pharmacokinetic Interactions

Alce's systemic clearance is officially documented to be affected by Theophylline. A 400 mg once-daily dose of Theophylline causes a 16% decrease in the clearance of Alce, resulting in increased systemic plasma exposure of the medication. Conversely, pharmacokinetic studies with medicinal products like Azithromycin, Erythromycin, Ketoconazole, and Pseudoephedrine showed no change in Alce's pharmacokinetics.

Intake Conditions and Population Notes

When taken with Food, the maximum plasma concentration ( Cmax) is reduced by 23%, and the time to reach peak concentration ( Tmax) is delayed by approximately 1.7 hours. The overall exposure (AUC) remains unchanged. Additionally, patients with Hepatic or Renal Impairment are noted to have decreased drug clearance, which may result in higher systemic exposure of Alce.

Mechanism of Action

How Alce Works

Alce exerts its pharmacological effect through targeted, receptor-mediated modulation that governs specific signaling patterns. The drug operates across two key mechanistic domains to modulate core regulatory systems associated with the histamine pathway.

1. Selective Receptor Antagonism

Alce functions as a highly selective antagonist of the H1 histamine receptor . It occupies the receptor site, preventing the body’s endogenous histamine (a primary acute inflammatory mediator) from binding and initiating the cell’s activation cascade. By blocking this early molecular step, the drug modifies the signal transduction pathway, resulting in reduced signaling within the targeted H1 receptor system.

2. Downstream Pathway Modulation

Beyond the initial receptor blockade, the mechanism engages in the modulation of associated inflammatory signaling cascades. It impacts downstream enzymatic mechanisms, resulting in reduced activity of other pro-inflammatory mediators and transmitters that often dominate during a dysregulated response. This targeted pathway interference impacts the regulation of processes driven by distinct signaling patterns. This results in a regulated signaling state within targeted pathways, which reduces the impact of excessive mediator activity and defines the resultant physiological pathway effects.

Dosage and Administration Information

Official Administration Guidelines for Alce

The use of Alce, containing Cetirizine Hydrochloride, is defined by multi-route protocols detailed in official documentation. The primary route of administration for systemic treatment is oral, available in forms such as tablets, syrups, and solutions. For adults and adolescents (age 12 and older), the standard oral regimen is typically 5 mg or 10 mg administered once daily, with the maximum intake not exceeding 10 mg in a 24-hour period. The medication may be taken with or without food.

Administration also encompasses specialized, non-oral forms. An intravenous (IV) injection is approved for acute conditions, administered as a 10 mg dose via an IV push over a period of one to two minutes. Additionally, a topical ophthalmic solution is available for localized use, requiring instillation of one drop in the affected eye twice daily.

Population-Specific Usage Protocols:

Dose adjustment is a mandated procedural requirement for patients with diminished renal or combined hepatic and renal function, often necessitating a reduction to 5 mg or less frequent administration. A lower starting dose of 5 mg once daily is often suggested for older adult patients. Pediatric administration is structured by age, with the oral solution requiring careful measurement with a calibrated device to ensure the correct quantity is administered.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Alce

Evidence for Symptom Management in Allergic Rhinitis

Research on Alce (Cetirizine Hydrochloride) has primarily utilized numerous short-term Randomized Controlled Trials (RCTs) and subsequent large-scale reviews to examine outcomes related to physical discomfort in individuals experiencing seasonal and perennial allergic rhinitis (hay fever and year-round allergies). These studies were applied in research contexts involving fluctuating or unstable symptoms, with the main goal of monitoring patient-reported outcomes describing perceived discomfort.

In these trials, researchers primarily monitored outcomes related to physical discomfort, such as nasal itching, sneezing, a runny nose, and watery eyes, often combining them into a Total Symptom Score (TSS). Studies monitored outcomes during the study period when Alce was compared against a placebo. Findings describe patterns observed in the studies conducted during periods of increased symptom activity. What remains uncertain is the full picture of long-term outcomes and the durability of any observed symptomatic patterns over many months or years.

Evidence for Managing Chronic Hives (Urticaria) and Itching

Alce was studied for its use in conditions characterized by fluctuating or episodic manifestations such as chronic urticaria (hives) and generalized pruritus (itching). The research explored short-term symptom changes, utilizing designs like short-term RCTs. These studies monitored outcomes linked to inflammatory or irritative states, focusing on measuring the severity of both the raised wheals (hives) and the intensity of the itching, often through a standardized scoring system. Findings indicate patterns related to physical manifestations (such as weal size and itching severity) over short assessment durations. Long-term outcomes for continuous management of chronic urticaria are not fully established by extensive RCTs.

Evidence in Pediatric and Other Special Populations

Alce was evaluated in studies including a wide demographic range, particularly in pediatric patients, with evidence describing its use for both allergic rhinitis and chronic urticaria in children as young as six months. Studies also examined its use in adolescents and specific age groups of older adults. Findings describe group patterns related to how outcomes changed in different age groups studied. Comparative evidence is lacking across the entire class of similar medications in extensive head-to-head trials.

Key Studies & References Chronic urticaria: off-label doses of cetirizine (NICE Evidence Summary)

Frequently Asked Questions (FAQ)

Common questions about Alce (FAQ)

Q: Why do doctors prescribe Alce instead of older treatments?

Alce is classified as a second-generation antihistamine, meaning it is designed to work as a highly selective H1-receptor antagonist. Official information indicates this design helps minimize the sedation that is often associated with older, first-generation antihistamines.

Q: Can Alce cause long-term side effects?

The FDA label includes a warning regarding a rare risk of severe itching, known as pruritus, that can occur when stopping the medication. This has been reported in some patients following long-term, daily use, typically for a few months or longer.

Q: Can elderly patients use Alce safely?

Official instructions advise that individuals 65 years and older should consult a healthcare provider for appropriate use. This consultation is recommended because dose adjustments may be necessary due to the higher likelihood of reduced renal function in this population.

Q: Does Alce affect liver function?

Rare instances of abnormal liver function, such as increased transaminases and bilirubin, have been reported in post-marketing experience. Regulatory information notes that these issues generally resolve upon discontinuation of the medicine. Individuals with existing liver disease should consult a healthcare professional.

Q: Can I take Alce if I have a history of heart problems?

Tachycardia, which is an increased heart rate, is reported as a rare adverse reaction based on post-marketing experience. If a patient has a history of heart problems, they should consult a healthcare professional.

Q: Is Alce used for short-term or long-term treatment?

The medication is approved for the treatment of symptoms associated with both seasonal and year-round (perennial) conditions, suggesting potential use for chronic management. Official labels include a warning about a rare risk of severe itching upon discontinuation after long-term, daily use.

Q: Does Alce affect my ability to drive or operate machinery?

Official product information advises patients to exercise caution when driving a car or operating potentially dangerous machinery. This warning is based on the potential for some individuals to experience somnolence (drowsiness) or dizziness while taking the medication.

Q: Does Alce cause weight gain?

Weight increased is listed as a rare adverse reaction based on post-marketing experience collected by regulatory bodies.

Q: What should I do if I forget a dose of Alce?

The official product labeling contains specific instructions regarding missed doses. Generally, this guidance advises patients not to take a double dose to make up for a forgotten one.

Q: How long does it typically take for Alce to start working?

According to official product labeling and clinical data, the onset of activity after a single standard dose is observed quickly. This onset occurs within 20 minutes in 50% of subjects studied and within one hour for 95% of subjects.

Q: Does Alce interact with birth control pills?

Regulatory studies investigating drug interactions have not identified any clinically significant interactions between the active ingredient of Alce and oral contraceptives.

Q: Can I take pain relievers like ibuprofen with Alce?

Regulatory drug interaction checks indicate that there is no significant drug-drug interaction between the active ingredient of Alce and common pain relievers such as ibuprofen.

Q: Is Alce considered a controlled substance?

Alce (Cetirizine Hydrochloride) is officially classified by regulatory bodies as a medication that is not a controlled substance under the U.S. Controlled Substances Act.

Q: What is the risk of dependency or addiction with Alce?

The product is not classified as having abuse potential or a risk of addiction. However, official safety communications note a rare risk of severe itching that can occur after stopping the medicine following long-term, daily use.

Q: What happens if I take too much Alce?

Regulatory documents contain a strong warning noting that, in the event of an overdose, medical help should be sought immediately or a Poison Control Center should be contacted.

Q: Do I need a special prescription to get Alce?

The most common forms of Alce (Cetirizine Hydrochloride) are officially classified by the FDA as a Human Over-the-Counter (OTC) drug.

Q: Can Alce cause problems with my vision?

Very rare adverse reactions affecting vision, such as blurred vision or accommodation disorder, are reported in post-marketing experience.

Q: Does Alce change my mood or behavior?

Adverse effects affecting mood or behavior have been reported in post-marketing experience. These include agitation (uncommon), and rare events like confusion or depression.

Q: Is Alce known to cause hair loss?

Alopecia, which is the medical term for hair loss, is listed as an adverse reaction that has been reported to regulatory bodies in post-marketing experience. The frequency of this event is not documented in the official labeling.

Q: What if I get sunburned while using Alce?

Photosensitivity, which describes a toxic reaction to sunlight, is listed as an adverse reaction that has been reported in post-marketing experience. The official documentation does not currently specify the frequency of this event.

Q: Can I crush or split the Alce tablet?

Regulatory directions for the chewable tablet formulation state that the tablets should be chewed or crushed completely before swallowing. Standard tablet formulations typically should be swallowed whole.

Q: What is the half-life of Alce?

The official product label contains pharmacokinetic information stating that the mean elimination half-life for the active ingredient is approximately 8.3 hours in healthy adult volunteers.

How should Alce be stored and disposed of?

Official Storage and Disposal Requirements

Alce (Cetirizine Hydrochloride) must be stored according to official regulatory documentation to ensure stability and safety.

Storage Conditions

Requirement	Specifics from Labeled Documents
Temperature	Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection	Protect from excess heat (above 40 C) and moisture. Some forms require protection from light.
Child Safety	Must be stored out of the reach and sight of children.
Container	Keep the medicine in its original container, tightly closed.
Stability	Oral solutions may have a limited shelf life (e.g., 3 to 6 months) after first opening.

Disposal Instructions

Unused or expired medication must be disposed of in accordance with local regulations or a drug take-back program. Official guidance advises against throwing medicines into wastewater or household waste and suggests consulting a pharmacist for guidance on proper disposal methods.

Alce